Northwell Study Offers Nuanced Hope for Long-Term Seizure Reduction in Chronic, Treatment-Resistant Epilepsy For millions of individuals worldwide, epilepsy remains one of the most challenging chronic neurological disorders to manage. Although many patients achieve seizure control through medication, roughly one-third…
Catalent Showcases SMARTag® ADC Pipeline Progress and New Enhanced Conjugate Class at 16th World ADC San Diego Catalent, Inc., a global leader in contract development and manufacturing services for advanced therapeutics, has unveiled a series of promising updates to its…
Serenity Mental Health Centers Expands Access to Breakthrough Ketamine Treatment in Colorado Springs Serenity Mental Health Centers, one of the nation’s fastest-growing providers of advanced psychiatric care, has announced the expansion of its ketamine treatment services in Colorado Springs. This…
Zoetis Appoints Kevin Esch as New R&D President to Succeed Rob Polzer in 2026, Marking a Strategic Leadership Transition in Global Animal Health Innovation Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, announced a major leadership transition in…
Genetix Biotherapeutics to Highlight U.S. Gene Therapy Implementation and Patient Experience Data at ASH 2025 Genetix Biotherapeutics Inc. announced that an analysis of recent patient experience data from the U.S. commercial implementation of its landmark gene therapies LYFGENIA™ and ZYNTEGLO™…
Tezspire Secures U.S. FDA Approval for Chronic Rhinosinusitis with Nasal Polyps, Expanding Its Reach Beyond Severe Asthma AstraZeneca and Amgen have announced that their jointly developed biologic, Tezspire (tezepelumab), has received U.S. Food and Drug Administration (FDA) approval for the…
Grifols Strengthens U.S. Diagnostic Manufacturing with New San Diego Facility Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global healthcare company specializing in plasma-derived medicines and innovative diagnostic solutions, has officially commenced production at its newly inaugurated facility in…
Taiho Pharma and Haihe Biopharma Form Exclusive Japanese Partnership for PI3Kα Inhibitor Risovalisib Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an exclusive license agreement for the development, manufacturing, and commercialization of…
Pulse Biosciences Grants Inducement Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) Pulse Biosciences, Inc. (Nasdaq: PLSE), a bioelectric medicine company pioneering applications of its proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology through the nPulse™ platform, announced that its…
Music Industry Icons Unite to Celebrate Tom Corson at City of Hope’s Spirit of Life Gala, Raising Funds to Advance Cancer Research, Survivorship Programs, and Integrative Therapies one of the largest and most advanced cancer research and treatment organizations in…
ViiV Healthcare CLARITY Study Shows Cabotegravir Long-Acting Injections More Acceptable and Preferred Over Lenacapavir GSK plc (LSE/NYSE: GSK) announced today that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has presented…
CVS Pharmacy Finalizes Nationwide Acquisition of Rite Aid and Bartell Drugs Assets, Expanding Access to Care Across the U.S. CVS Pharmacy, a subsidiary of CVS Health, today announced the successful completion of its acquisition of select Rite Aid assets across…